%0 Journal Article
%T Angiogenesis inhibitors for small cell lung cancer
%A Cheol-Kyu Park
%A In-Jae Oh
%A Sang-Yun Song
%A Young-Chul Kim
%J SCIE-indexed Journal
%D 2017
%R 10.21037/13386
%X Small-cell lung cancer (SCLC) accounts for approximately 12¨C15% of all lung cancers and is characterized by a rapid growth rate and metastasis at the time of diagnosis. Despite its initial sensitivity to £¿rst-line chemotherapy, rapid acquisition of resistance to subsequent lines of therapy is usually observed. Although there is a plethora of new drugs being developed for non-small cell lung cancer (NSCLC), there is still a shortage of treatment regimens other than the combination therapy containing platinum and etoposide or irinotecan
%U http://tcr.amegroups.com/article/view/13386/html